Global Narcolepsy Therapeutics Market Share

Statistics for the 2023 & 2024 Global Narcolepsy Therapeutics market share, created by Mordor Intelligenceā„¢ Industry Reports. Global Narcolepsy Therapeutics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Global Narcolepsy Therapeutics Industry

The narcolepsy therapeutics market is moderately competitive. Collaborations and acquisitions to share technology and costs for innovation in the field are expected to be observed. The market is driven by the development of novel therapies and approval by international regulatory agencies. Some of the major players include companies such as Avadel Pharmaceuticals Inc., Harmony Biosciences (BIOPROJET), Jazz Pharmaceuticals PLC, Ligand Pharmaceuticals Incorporated, Novartis, Shionogi Inc., Takeda Pharmaceutical Company Limited, and Teva Pharmaceuticals USA Inc., among others.

Narcolepsy Therapeutics Market Leaders

  1. Jazz Pharmaceuticals plc

  2. Takeda Pharmaceutical Company

  3. Teva Pharmaceuticals USA, Inc.

  4. Shionogi Inc

  5. Novartis International AG

*Disclaimer: Major Players sorted in no particular order

Narcolepsy Therapeutics Market Concentration

Narcolepsy Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)